![](https://nthumb.tpgimages.com/mid2_com_img/1339/29253/TOP27285888.jpg)
Alirocumab (tradename Praluent) pen in use to administer subcutaneous injection. Alirocumab is a human monoclonal antibody which is used to treat high cholesterol in adults whose cholesterol is not controlled by diet and statin treatment. It is an antibody to PCSK9 (proprotein convertase subtilisin/kexin type 9), a circulating protein that modulates the activity of cholesterol receptors in the liver.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP27285888
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
healthcaremedicalmedicinemedicationpharmaceuticalpharmaceuticspharmacologicalpharmacologytreatmentdrugdrugsprescriptionwhitebackgroundcutouttherapyalirocumabpraluentinjectionpeninjectorhumanmonoclonalantibodyhighelevatedcholesterolpcsk9proproteinconvertasesubtilisin/kexintype9ldlliverreceptorsubcutaneousskinpeoplepersonelderlyoldseniorwomanfemalethighadultcut-outcutoutcut-outscutoutscutouts
9adultalirocumabantibodybackgroundcholesterolconvertasecutcutcut-outcut-outscutoutcutoutsdrugdrugselderlyelevatedfemalehealthcarehighhumaninjectioninjectorldllivermedicalmedicationmedicinemonoclonaloldoutoutspcsk9penpeoplepersonpharmaceuticalpharmaceuticspharmacologicalpharmacologypraluentprescriptionproproteinreceptorseniorskinsubcutaneoussubtilisin/kexintherapythightreatmenttypewhitewoman